Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer
Year: 2026
Type: letter
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-26-01356
Authors: Michael J. Morris, Andrew J. Armstrong
Institutions: Memorial Sloan Kettering Cancer Center, Duke University
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7167812694